Trial NCT03151057

View at ClinicalTrials.gov 
Org. Study IDs: J1633
Secondary IDs: IRB00157704

Last trial update was posted on 2024-03-12

MeSH Interventions

Idelalisib

MeSH Conditions

Leukemia, Lymphocytic, Chronic, B-Cell Lymphoma Lymphoma, Mantle-Cell Lymphoma, Non-Hodgkin

Other Conditions

B Cell Chronic Lymphocytic Leukemia B Cells-Tumors Follicular Lymphoma Large B-Cell Diffuse Lymphoma of Bone (Diagnosis) Mantle Cell Lymphoma

Stopping Reasons

Safety endpointreached

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID